摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,5-二氟-4-甲基苯甲酸 | 223382-10-3

中文名称
2,5-二氟-4-甲基苯甲酸
中文别名
——
英文名称
2-[4-(azetidin-3-yl)piperazin-1-yl]pyrimidine
英文别名
2-(4-azetidin-3-yl-piperazin-1-yl)-pyrimidine;2-(4-(Azetidin-3-yl)piperazin-1-yl)pyrimidine
2,5-二氟-4-甲基苯甲酸化学式
CAS
223382-10-3
化学式
C11H17N5
mdl
——
分子量
219.289
InChiKey
OJZAQAFBVYOSBK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    398.8±52.0 °C(Predicted)
  • 密度:
    1.219±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.1
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    44.3
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS
    申请人:Janssen Pharmaceutica, NV
    公开号:US20130184251A1
    公开(公告)日:2013-07-18
    Disclosed are compounds, compositions and methods for treating diseases, syndromes, conditions and disorders that are affected by the inhibition of MGL, including pain. Such compounds are represented by Formula (I) as follows: wherein Y, r, R2 and Z are defined herein.
    本发明涉及一种化合物、组合物和治疗方法,用于治疗受到MGL抑制影响的疾病、综合征、病况和紊乱,包括疼痛。这些化合物由以下式子(I)所表示:其中Y、r、R2和Z的定义如下。
  • Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
    申请人:Chevalier Kristen
    公开号:US08415341B2
    公开(公告)日:2013-04-09
    Disclosed are compounds, compositions and methods for treating diseases, syndromes, conditions and disorders that are affected by the inhibition of MGL, including pain. Such compounds are represented by Formula (I) as follows: wherein Y, r, R2 and Z are defined herein.
    本发明涉及抑制MGL的化合物、组合物和治疗疾病、综合症、病况和疾患的方法,这些疾病、综合症、病况和疾患受到MGL的抑制影响,包括疼痛。这些化合物由以下公式(I)表示:其中Y、r、R2和Z如本文所定义。
  • Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase
    作者:Christopher R. Butler、Elizabeth M. Beck、Anthony Harris、Zhen Huang、Laura A. McAllister、Christopher W. am Ende、Kimberly Fennell、Timothy L. Foley、Kari Fonseca、Steven J. Hawrylik、Douglas S. Johnson、John D. Knafels、Scot Mente、G. Stephen Noell、Jayvardhan Pandit、Tracy B. Phillips、Justin R. Piro、Bruce N. Rogers、Tarek A. Samad、Jane Wang、Shuangyi Wan、Michael A. Brodney
    DOI:10.1021/acs.jmedchem.7b01531
    日期:2017.12.14
    Monoacylglycerol lipase (MAGL) is the main enzyme responsible for degradation of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the CNS. MAGL catalyzes the conversion of 2-AG to arachidonic acid (AA), a precursor to the proinflammatory eicosannoids such as prostaglandins. Herein we describe highly efficient MAGL inhibitors, identified through a parallel medicinal chemistry approach that highlighted the improved efficiency of azetidine and piperidine-derived carbamates. The discovery and optimization of 3-substituted azetidine carbamate irreversible inhibitors of MAGL were aided by the generation of inhibitor-bound MAGL crystal structures. Compound 6, a highly efficient and selective MAGL inhibitor against recombinant enzyme and in a cellular context, was tested in vivo and shown to elevate central 2-AG levels at a 10 mg/kg dose.
  • HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITOR
    申请人:Janssen Pharmaceutica N.V.
    公开号:EP2421852A1
    公开(公告)日:2012-02-29
  • US8415341B2
    申请人:——
    公开号:US8415341B2
    公开(公告)日:2013-04-09
查看更多